MeSH tree: B04.280.382.150
A UCLA research team has found a new way to prompt the immune system to kill cells infected with cytomegalovirus (CMV), a life-threatening infection that is particularly deadly in immunocompromised people.
Sep 12, 2025
0
54
Northwestern Medicine scientists have discovered how a common virus linked to birth defects and chronic illness manipulates its host's DNA, according to a new study published in Nature Communications.
Aug 28, 2025
0
18
Cytomegalovirus (CMV), a common virus in the Herpesviridae family, infects approximately half of all adults in the United States, most of whom experience mild or no symptoms. While the virus usually remains latent in the ...
Aug 13, 2025
0
11
New research from the University of Pittsburgh School of Medicine and La Jolla Institute for Immunology, published today in Nature Microbiology, reveals an opportunity for developing a therapy against cytomegalovirus (CMV), ...
Jun 30, 2025
0
100
A new study led by the University of Oxford has revealed that a common and usually harmless virus may positively influence how skin cancer patients respond to current treatments.
Apr 23, 2025
0
62
Most humans have long-lived infections in various tissues—including in the nervous system—that typically do not result in disease. The microbes associated with these infections enter a latent stage during which they quietly ...
Mar 28, 2025
0
36
A new Oregon Health & Science University and Weill Cornell Medicine co-authored study provides critical insight for the development of a vaccine that can more effectively block the spread of cytomegalovirus (CMV) across the ...
Mar 13, 2025
0
48
At UC Davis Comprehensive Cancer Center, one scientist's sleepless nights are driven by the mysteries of virus-host interactions. Researcher Yoshihiro Izumiya is delving into the complex world of herpesviruses. These viruses ...
Nov 1, 2024
0
41
Continuing their journey to develop a vaccine for HIV, Oregon Health & Science University researchers have identified a gene that could have prevented their vaccine from working in humans.
Oct 30, 2024
0
115
New research led by Oregon Health & Science University reveals a promising approach to developing a universal influenza vaccine—a so-called "one and done" vaccine that confers lifetime immunity against an evolving virus.
Jul 19, 2024
0
180
